The relevance of binding and hydrolysis of type IV collagen in the action of hemorrhagic SVMPs has been also shown for the P-III SVMP jararhagin[20],[26],[63]and for a hemorrhagic metalloproteinase from the prokaryoteVibrio vulnificus[64]. tissue samples showed a decrease in the immunostaining of type IV collagen after injection of BaP1, but not by leuc-a. Proteomic analysis by LC/MS/MS of exudates collected from injected muscle revealed higher amounts of perlecan, and types VI and XV collagens, in exudates from BaP1-injected tissue. The differences in the hemorrhagic activity of these SVMPs could be explained by their variable ability to degrade key BM and associated ECM substratesin vivo, particularly perlecan and several non-fibrillar collagens, which play a mechanical stabilizing role in microvessel structure. These results underscore the key role played by these ECM components in the mechanical stability of microvessels. == Introduction == Zinc-dependent metalloproteinases are abundant components in the proteomes PP1 of many snake venoms, especially in those of species of the family Viperidae[1],[2]. Snake venom metalloproteinases (SVMPs) are multi-domain proteins which have been classified in various classes on the basis of their domain composition[1]. Class P-I SVMPs comprise enzymes having, in their mature protein, only the metalloproteinase domain, whereas class P-II SVMPs present, in addition to the catalytic domain, a disintegrin domain, which may be cleaved to generate disintegrins. Enzymes of the P-III class have disintegrin-like and cysteine-rich domains following the metalloproteinase domain[1]. SVMPs play key roles in envenomations by snakes of the family Viperidae, and probably also in the case of some species of the family Colubridae (sensu lato)[3][7]. One of the most notorious effects of SVMPs is their ability to disrupt microvessels, provoking local and systemic hemorrhage[3],[8]. It has been proposed that this effect is the consequence of the hydrolysis of proteins forming the basement PP1 membrane (BM) of capillary blood vessels, a phenomenon that has been consistently demonstratedin vitro[9][17]. Although studies on BM damagein vivohave been scarce, a number of observations support the concept that capillary vessel BM is indeed affected by SVMPs when injected in tissues[16],[18][20]. A unified hypothesis, based on a two-step mechanism, has been proposed to explain the pathogenesis of hemorrhage by SVMPs[8],[21]. Initially, SVMPs hydrolyze key peptide bonds in Rabbit polyclonal to Amyloid beta A4.APP a cell surface receptor that influences neurite growth, neuronal adhesion and axonogenesis.Cleaved by secretases to form a number of peptides, some of which bind to the acetyltransferase complex Fe65/TIP60 to promote transcriptional activation.The A BM and supporting extracellular matrix (ECM) components, promoting the weakening of the mechanical stability of BM. As a consequence, the hemodynamic biophysical forces normally operating in the vasculature, such as microvessel wall tension and shear stress, provoke the distention of the weakened capillary, which leads to microvessel disruption and extravasation[8]. Despite sharing a highly similar structure in their catalytic domain, SVMPs greatly differ in their capacity to induce hemorrhage[8],[22]. In general, P-III SVMPs are more potent hemorrhagic toxins than P-I SVMPs. This is likely to depend on the presence, in the former, of extra domains in addition to the catalytic one, since exosites in disintegrin-like and cysteine-rich domains enable these enzymes to bind to relevant targets in the extracellular matrix or in endothelial cells[1],[20],[23][26]. Moreover, P-III SVMPs are highly resistant to inhibition by the plasma proteinase inhibitor 2-macroglobulin (2M), whereas P-I SVMPs are readily inhibited[27][32]. On the other hand, an intriguing observation is that a significant variation in hemorrhagic potency occurs also within the class P-I SVMPs[33],[34]. Since these enzymes comprise the metalloproteinase domain only, such difference in hemorrhagic activity depends on variations within this domain. Various proposals have been presented for identifying key structural determinants for hemorrhagic activity in P-I SVMPs[34][39], PP1 although this issue remains largely unsolved. The functional differences between hemorrhagic and non-hemorrhagic P-I SVMPs have not been clarified either, as both groups are able.